Biotech and Pharmaceuticals
Why Eli Lilly’s Obesity Pill Is Still a Strong Contender Against Novo’s Wegovy Despite Mixed Investor Reactions
Eli Lilly’s stock has been on a rollercoaster ride recently. It took a hit after the company released data on ... Read more
Transform Your Health: FDA Approves Signos’ Revolutionary Glucose Monitoring System for Weight Loss!
The FDA recently approved Signos’ innovative glucose monitoring system designed specifically for weight loss. This marks a significant step for ... Read more
Save Big: Novo Nordisk Slashes Ozempic Prices for Cash-Paying U.S. Diabetes Patients
Novo Nordisk recently announced a significant price drop for Ozempic, their diabetes treatment. This move reflects growing pressure on drugmakers ... Read more
“Breaking News: Pfizer’s COVID Vaccine for Kids Under 5 Faces Potential FDA Authorization Withdrawal”
The FDA is considering revoking its approval for Pfizer’s COVID-19 vaccine for healthy kids under 5. This decision, if finalized, ... Read more
Eli Lilly Boosts 2025 Forecast with Soaring Mounjaro and Zepbound Sales: Quarterly Results Exceed Expectations!
Eli Lilly recently announced impressive second-quarter results, surpassing expectations mainly due to strong sales of its weight loss and diabetes ... Read more
Eli Lilly’s Breakthrough Obesity Pill Achieves 12% Weight Loss in Key Late-Stage Trial: A Game Changer for Weight Management
Eli Lilly recently shared exciting news about its new weight loss pill. In a late-stage trial, the highest dose helped ... Read more
Trump Warns: Pharma Tariffs Could Soar to 250%—What This Means for You
President Donald Trump recently discussed potential tariffs on imported pharmaceuticals during an interview with CNBC. He mentioned that these tariffs ... Read more
Pfizer Boosts 2025 Profit Forecast: Discover How Cost Cuts and Stellar Quarterly Results Drive Growth
Pfizer recently raised its profit outlook for the year, pointing to strong performance and successful cost-cutting measures. The company now ... Read more
Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more
UnitedHealth Predicts Lower 2025 Earnings Amid Rising Medical Costs: What It Means for Insurers
UnitedHealth Group recently shared its outlook for 2025, and the news isn’t great. The company anticipates adjusted earnings of at ... Read more
